Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

671
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
671
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.3K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.3K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

4.1K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.1K
Enzyme Inhibition01:30

Enzyme Inhibition

80.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
80.0K
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

684
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
684

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unfurling the role of dysferlin's C2A domain.

The Journal of general physiology·2026
Same author

Cholesterol pools cooperate to modulate HCN channels.

The Journal of general physiology·2026
Same author

ID helps verify coincidence detection.

The Journal of general physiology·2026
Same author

Cavβ dances the two-step with VSD II.

The Journal of general physiology·2025
Same author

The origins of oscillations.

The Journal of general physiology·2025
Same author

Skeletal muscle gets some help down the stretch.

The Journal of general physiology·2025

Related Experiment Video

Updated: Sep 24, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

A Kv2 inhibitor traps itself in place.

Ben Short

    The Journal of General Physiology
    |May 6, 2022
    PubMed
    Summary

    RY785 binding to Kv2 channels requires voltage activation, not channel opening. This interaction promotes voltage sensor deactivation, trapping the molecule within the channel

    Area of Science:

    • Biophysics
    • Molecular Biology
    • Ion Channel Research

    Background:

    • Kv2 channels are crucial voltage-gated ion channels involved in neuronal excitability.
    • Understanding the molecular mechanisms of Kv2 channel modulation is key to developing therapeutics for neurological disorders.

    Discussion:

    • The study reveals that RY785 accesses the Kv2 channel central cavity only after voltage activation, independent of channel opening.
    • This unique binding mechanism involves RY785 promoting voltage sensor deactivation, effectively trapping it within the channel.

    Key Insights:

    • Voltage activation, not channel opening, is the prerequisite for RY785 interaction with Kv2 channels.
    • RY785 acts as a voltage sensor deactivation promoter, leading to its self-trapping within the channel's central cavity.

    More Related Videos

    Reconstitution of a Kv Channel into Lipid Membranes for Structural and Functional Studies
    10:22

    Reconstitution of a Kv Channel into Lipid Membranes for Structural and Functional Studies

    Published on: July 13, 2013

    19.5K
    High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
    10:07

    High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

    Published on: January 27, 2013

    15.2K

    Related Experiment Videos

    Last Updated: Sep 24, 2025

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
    10:33

    Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

    Published on: October 26, 2015

    11.4K
    Reconstitution of a Kv Channel into Lipid Membranes for Structural and Functional Studies
    10:22

    Reconstitution of a Kv Channel into Lipid Membranes for Structural and Functional Studies

    Published on: July 13, 2013

    19.5K
    High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
    10:07

    High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

    Published on: January 27, 2013

    15.2K

    Outlook:

    • Further research can explore the precise structural interactions between RY785 and Kv2 channel voltage sensors.
    • This mechanism may offer novel strategies for modulating Kv2 channel function in disease contexts.